These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3523975)

  • 1. [Clinical experience with the antiarrhythmic propafenone (Rytmonorm)].
    Stejfa M; Spác J; Vítovec J; Havlát F
    Vnitr Lek; 1986 Apr; 32(4):393-7. PubMed ID: 3523975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Propafenone--a new antiarrhythmic agent. Clinical experience].
    Kozák P; Stárek A; Hes I; Spacek R
    Cas Lek Cesk; 1985 Mar; 124(13):407-10. PubMed ID: 3891090
    [No Abstract]   [Full Text] [Related]  

  • 3. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P; De Toma L; Mangini SG; Scrutinio D; Lagioia R; De Nicolò M
    Cardiologia; 1983 Sep; 28(9):791-801. PubMed ID: 6398703
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F; Disertori M; Vergara G; Guarnerio M; Dal Forno P; Padrini R; Gobbato S; Ferrari M
    Int J Clin Pharmacol Res; 1983; 3(2):101-5. PubMed ID: 6679511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Propafenone--a new generation anti-arrhythmia agent].
    Fischer M
    Med Klin; 1980 Jan; 75(1):39-41. PubMed ID: 6988688
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
    Sanna G; Meoli P; Bianchini C; Rovelli F
    G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J
    Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A; Marcos Sánchez F; Górgolas Hernández-Mora P; Durán Pérez-Navarro A
    Rev Clin Esp; 1986 Jun; 179(2):101. PubMed ID: 3738054
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of anti-arrhythmia agents].
    Klein G; Wirtzfeld A; Schlegl J; Himmler C; Neiss A
    Med Klin; 1980 Nov; 75(24):853-5. PubMed ID: 6160379
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propafenone: a new anti-arrhythmic agent for the treatment of ventricular ectopic beats].
    Molinis G; Valente M; Tuniz D; Maisano G
    Cardiologia; 1982; 27(2):211-7. PubMed ID: 6927434
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction.
    Rehnqvist N; Ericsson CG; Eriksson S; Olsson G; Svensson G
    Acta Med Scand; 1984; 216(5):525-30. PubMed ID: 6395642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-arrhythmic effects and electrophysiological actions of propafenone].
    Zheng DS; Wang BY
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):418-20. PubMed ID: 3938327
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.